ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help High-Risk patients get Life-Saving stem cell transplants
Disease control Recruiting nowThis study tests whether Darzalex Faspro can safely lower donor-specific antibodies (DSAs) in adults with blood cancers who are at high risk of rejecting a stem cell transplant. Participants receive the drug before standard transplant preparation to reduce DSA levels enough to al…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New immune therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called LV009 injection for people with certain blood cancers (non-Hodgkin lymphoma and acute lymphoblastic leukemia) that have not responded to standard therapy or have returned. The treatment uses the patient's own immune cells, modif…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), ADULT
Phase: EARLY_PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC